Stereotaxis, Inc. (STXS) |
| 1.32 -0.01 (-0.75%) 09-15 16:00 |
| Open: | 1.32 |
| High: | 1.335 |
| Low: | 1.31 |
| Volume: | 374,242 |
| Market Cap: | 129(M) |
| PE Ratio: | -7.76 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 1.51 |
| Resistance 1: | 1.42 |
| Pivot price: | 1.37 |
| Support 1: | 1.26 |
| Support 2: | 1.05 |
| 52w High: | 3.59 |
| 52w Low: | 1.24 |
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Sat, 05 Sep 2026
Stereotaxis: A Real Product Story, But The Stock Already Prices In Success (NYSE:STXS) - Seeking Alpha
Thu, 03 Sep 2026
A Hungarian hospital treated over 70 heart patients with robots in just over a month - Stock Titan
Sun, 23 Aug 2026
STXS | Stereotaxis, Inc. Common Stock Financials - Revenue Breakdown - quiverquant.com
Mon, 17 Aug 2026
Stereotaxis Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Tue, 11 Aug 2026
Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Tue, 21 Jul 2026
Stereotaxis to Discuss Robotic Intervention Results on Aug. 11 - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
